*These vaccines should be outlawed, the CDC vaccine schedule radically revised—* *and the big rush to develop, and ultimately force on all of us, a COVID-19 vaccine* *now seriously questioned.*
*MCM* *"As a consequence, this vaccine should be considered defective and potentially * *dangerous to human health, **in particular for the pediatric population, which is * *much more vulnerable to genetic and autoimmune damage **due to the immaturity * *of the immunity systems."* First peer-reviewed publication on MMRV vaccines (Priorix Tetra) https://www.corvelva.it/speciale-corvelva/vaccinegate-en/first-peer-reviewed-publication-on-mmrv-vaccines-priorix-tetra.html VACCINEGATE - EN <https://www.corvelva.it/speciale-corvelva/vaccinegate-en.html> STAFF CORVELVA <https://www.corvelva.it/component/contact/contact/4-uncategorised/1-corvelva-coordinamento-regionale-veneto-per-la-liberta-delle-vaccinazioni.html?Itemid=200> 31 MARZO 2020 [image: First peer-reviewed publication on MMRV vaccines (Priorix Tetra)] Finally here we are -after almost two years- the first peer-reviewed publication of our analyses is being released and many others are going to be published. The aim of this article is to summarize the following issues: what has been published, what is its validity, and why it is important for our investigation on vaccines. All these arguments will be treated in a colloquial and non-technical way in the first pages, while from page 3 on, there will be a technical study in order to allow the specialists of this sector to evaluate the article in itself. The article published on “F1000 Research”1 is the outcome of the initial study performed by one of the laboratories that Corvelva Association appointed to carry out the analyses. We remind you - because more than two years have passed since the beginning of this work and many other results have been added to the first ones – that the first major issue that we had to investigate was the abnormal amount of human DNA found within the vaccines analyzed. The initial analyses showed that both the quadrivalent MMRV vaccines analyzed contained from 1 to 2.7 microgram/ vial (as published in the present article) and we decided to report publicly and immediately such results because, simply, it was not expected that such an amount of DNA could be present within a vaccine. Apart from the considerations and conclusions achieved by the study, which are strictly technical and therefore comprehensible only to those who work in the field of metagenomic research, what is observed in the graphs is that the two vaccine samples contain a high percentage of human DNA readings in addition to those expected from the chickenpox virus genome (Human alphaherpes virus 3), the only detectable one among four, as a DNA-seq type of analysis was presented in the article. However, we would like to point out that the quantities of DNA that were found and confirmed by the same method that is now validated here were even higher: up to 3.7 micrograms per vial, leading to a considerable difference from batch to batch. In fact, in our report released on December 22 20182 the results obtained from the analysis of different batches from those discussed in the present article were reported, and then confirmed by interlaboratory analysis that are still in process of publication. Therefore, what should be considered as of major interest in the present publication is that it validates the method we used, gives an important point to the discussions on the "type" of analysis carried out, and as a consequence it confirms in a definitive way all the studies that have been subsequently carried out with the NGS method: the in-depth analysis on the type of genetic material, the presence of adventitious viruses, the great absence of attenuated viruses that should be present and the amount of human DNA that was completely out of control (also because very different from sample to sample), the mutant population, phages, DNA from other species, and so on. You can find all the results summarized on our web site3 . Everything we have denounced in recent years, from a biological point of view, reporting thoroughly the results to the control bodies, takes on a more relevant scientific connotation (even if, we repeat it again, it was not the peer-reviews that had to worry but the data presented, very serious in their content and their possible implications for human health). However, now that the publication of the method has been done, we will demand the answers that we have not yet been given. These results unquestionably confirm the presence of fetal DNA in Priorix tetra vaccines, in variable quantities from batch to batch, indicating poor quality control of these pharmaceutical products. We’d also like to remind the report on the entire MRC-5 genome sequencing published in Corvelva website on September 27 20194 showing the deep modification of this DNA even in genes linked to the development of tumor diseases (this data also will soon be published). The contaminating fetal DNA found in all the analysed samples in variable (i.e. uncontrolled) quantities is up to 300 times higher than the limit imposed by the EMA for carcinogenic DNA (10 ng/dose, corresponding to the DNA contained in about 1000 cancer cells, on the basis of a statistical calculation, while the precautionary limit is 100 pg/dose), a limit that must necessarily be applied also to fetal DNA inevitably contaminating Priorix Tetra vaccine. As a consequence this vaccine should be considered defective and potentially dangerous to human health, in particular for the paediatric population which is much more vulnerable to genetic and autoimmune damage due to the immaturity of the immunity systems. As anticipated, the following part of the article is a more "technical" and difficult to understand for non-experts, therefore we decided, even for transparency purposes, to attach to this document also the "EMA Dossier - NGS Dossier Discussion on the results of the vaccine quality survey ". We had to extrapolate only the part that could be published, that is 50 pages of the dossier compared to the 200 pages of the NGS, since much of the information contained and registered to the regulatory bodies must remain confidential. The strict law of science dictates that a piece of information can be published in a journal only if it is original and since we have other work in progress, we do not want to put it at risk. EMA - NGS Dossier Discussion on the results of the vaccine quality survey". - <https://bit.ly/342XKi7>https://bit.ly/342XKi7 Finally, to avoid misunderstandings, we would like to highlight the part of "Financing Declaration" from the above mentioned publication: *"The B1 and B2 metagenomic sequencing was funded by Corvelva (non-profit association, Veneto, Italy), under a service contract with the laboratory. No other contribution was involved in supporting the work. The funders had no role in the design of the study, the collection and analysis of data, the decision to publish or the preparation of the manuscript"* *Click on the link for the rest.* -- If you appreciate News From Underground, please consider making a donation — either a one-time gift or a monthly subscription: http://markcrispinmiller.com/support/ Thank you for your support. Ways to unsubscribe: 1) send a blank email to newsfromunderground+unsubscr...@googlegroups.com PLEASE NOTE: you must unsubscribe using the SAME email with which you subscribed 2) go to http://groups.google.com/group/newsfromunderground and click on the "Unsubscribe or change membership" link in the yellow bar at the top of the page, then click the "Unsubscribe" button on the next page. For more News From Underground, visit http://markcrispinmiller.com --- You received this message because you are subscribed to the Google Groups "News From Underground" group. To unsubscribe from this group and stop receiving emails from it, send an email to newsfromunderground+unsubscr...@googlegroups.com. To view this discussion on the web visit https://groups.google.com/d/msgid/newsfromunderground/CAGxB6W-dtVkK2TC%2BioSxd5Z0WyWWtzmyRNsZu_nEF-8PE0g2%3Dw%40mail.gmail.com.
